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Different research groups have identified microorganisms on breast implants by sonication
with significant correlation to the rate of capsular contracture. This substantiated the hypoth-
esis of an infectious etiology of capsular contracture. However, no clinical consequence has
been drawn from these results yet. Aim of this study was to review sonication results from
breast implants and to evaluate the current preoperative antibiotic regime for breast-implant
surgery.
Methods
We compared breast implant sonication culture results from published reports and our own
database. Current perioperative antibiotic recommendations were compared with the sus-
ceptibility profile of the found organisms.
Results
We found Coagulase-negative staphylococci and Propionibacteria to be the main group of
microorganism found by sonication on explanted breast implants. Most guidelines recom-
mend cephalosporins for preoperative antibiotical prophylaxis for breast-implant surgery.
Conclusion
There is a discrepancy between antibiotic activity of commonly used antibiotics for preoper-
ative prophylaxis of surgical site infections, and microorganisms found by sonication on
breast implants, suspected to trigger the formation of capsular contracture. A targeted anti-
biotic prophylaxis for breast implant surgery with glycopeptides (e.g. Vancomycin) should
be considered for the prevention of capsular contracture.
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Introduction
Periprosthetic capsular contracture is one of the leading long term complications following
reconstructive or aesthetic breast implant surgery. It has a reported incidence of 5–22% in the
literature[1], depending on follow-up time and surgical indication for breast implantation.
Capsular contracture of Baker grade 3 and 4[2] is a severe complication given the need for sur-
gical revision due to malposition and pain. The etiology of capsular contracture, it´s treatment
and prevention are not entirely understood. Many possible causative factors were discussed,
e.g. immune mechanisms in foreign body reactions, postoperative haematoma or individual
predisposition[1]. However, evidence-based support for these theories is lacking.
A chronic subclinical Infection, caused by biofilm forming bacteria (e.g. Coagulase-negative
staphylococci (CNS) or Propionibacterium spp.) has already been suspected decades ago to
play a role in the etiology of capsular contracture[3]. This hypothesis was supported by several
studies, showing correlations between antiinfective measures preventing contamination of
breast implants and lower rates of capsular contracture[4][5][6]. However, for a long time the
consistent detection of microorganisms on explanted breast implant surfaces and it´s associa-
tion to capsular contracture was not evident, possibly due to the lack of sensitivity of conven-
tional culture methods.
Sonication of medical devices has been introduced as a valid tool to detect biofilms on vari-
ous implant surfaces and to identify organisms by culturing the sonication fluid[7]. Implants
are put into a bath, to which ultrasound is applied, breaking down any possible biofilm. This
technique has significantly improved the detection of implant associated infections in orthope-
dic surgery[8]. Sonication of breast implants eventually allowed for the consistent detection of
the same microorganism and significant correlation to capsular contracture[9][10][11], which
strongly supports an infectious etiology of capsular contracture.
The use of systemic antibiotics for the prevention of capsular contracture has only a few
proponents in the surgical literature, which reported no effect on the rate of capsular contrac-
ture using cephalosporins or penicillins [12][13]. 97% of plastic surgeons stated to use cefazo-
lin as antibiotic prophylaxis for breast implantation surgery in breast reconstruction in a
recent study[14]. Given that the detection and identification of microorganism on breast
implants was reported by different groups with significant association between capsular con-
tracture and sonication result, a more targeted antibiotic regimen for the prevention of capsu-
lar contracture should be considered.
To the best of our knowledge, this is the first paper comparing sonication results from dif-
ferent sources including our own data. Aim of this study was to evaluate the suitability of com-
monly used antibiotic prophylaxis against microorganisms detected by sonication of breast
implants.
Methods
After revision of the proposed study protocol with a waiver for additional informed consent
and final approval by the local ethical board (Medical University of Graz, vote # EK 28–626 ex
15/16), we retrospectively analyzed breast implant sonication data from otherwise asymptom-
atic patients, aged 18 years and above, who were carriers of uni- or bilateral breast implants
and had an elective implant removal at the University Hospital Graz, Graz, Austria, between
January 2015 and April 2016. Patients with signs of local infection in the breast region (e.g.
redness, pain, swelling etc.) or systemic infection (e.g. elevated temperature, elevated leucocyte
count, elevated c-reactive protein) were excluded. We compared these breast implant sonica-
tion results to sonication data of previously published papers. Studies on sonication for breast
implants were reviewed, and compared for all retrieved data points.
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Current recommendations for perioperative antibiotic prophylaxis for breast implant sur-
gery were extracted from published guidelines, compared to actual antibiotic susceptibility of
organisms found in sonication specimens, and profiled for their suitability in perioperative
prophylaxis for surgery involving breast implants.
Patient data collection
Following ethical board approval, the following patient data were extracted from electronic
patient records (SAP R/3, SAP Germany, Walldorf, Germany): Patient age, sex, reason for
implantation, reason for explantation, indwelling time of implants, placement of implants,
degree of capsular contracture, sonication culture result.
Degree of capsular contracture was classified according to Baker[2]: grade IV—hard, pain-
ful contraction, contracted capsule visible, distorted shape or/and placement; grade III—breast
harder than normal, implant visible and palpable, distortion of the implant; grade II—implant
palpable, implant not visible, increased firmness of breast; grade I—normal soft breast.
Breast implant: Sonication and culture
Immediately after removal, implants were put in sterile 1000ml containers (Pathopack, Intel-
sius, York, UK) by the surgeon and covered with 500ml of sterile Ringer solution. The contain-
ers were transported to the Institute of Clinical Hygiene and Microbiology, Medical University
of Graz for sonication analysis. The closed container was fist vortexed for 30 seconds at maxi-
mum speed. The container was then placed into the ultrasound bath and was sonicated for 5
minutes at a frequency of 40 kHz and 200Watt power. The container was then again vortexed
for 30 seconds to distribute detached biofilm components in the fluid homogeneously. The
container was next opened in a laminar air-flow biosafety cabinet, to avoid contamination,
and 20 ml was removed from the fluid. 10 ml were transferred in to an aerobic blood culture
bottle and 10 ml were transferred into an anaerobic blood culture bottle. Blood culture bottles
were incubated at 37˚C for 7 days. Conventional microbiological techniques were used to
identify positive cultures.
Comparing results from other sonication publications
A systematic review of the literature was performed to identify studies that used sonication
analysis for explanted breast implants. For identification of studies, we used the following
search terms and search terms combination in the PubMed database: ("breast implants" OR
"breast implant") AND ("sonication" OR "broth culture") AND ("capsular contracture" OR
"capsular fibrosis"). Inclusion criteria for studies were as follows: Full text articles on breast
implants explanted and swiftly analyzed by sonication without further processing. Exclusion
criteria were: duplicate publication of data. Articles were included on the 15.12.2016. The sys-
tematic review was conducted by FMJR and JH. From included studies demographical data,
clinical data as well as sonication results were copied from demographical and clinical data
tables from full text articles (Table 1 and S1 Table) Case reports were excluded, and no further
restriction on levels of evidence below that was applied. Accumulated data was compared
using descriptive statistics.
Review of antibiotic agents recommended by guidelines for prophylactic
use in surgery to prevent surgical site infection
Current guidelines for prevention of surgical side infection were collected and, if available,
antibiotic recommendations specifically for breast implant surgery were reviewed.
Antibiotic prophylaxis for capsular contracture
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Recommended antibiotical agents and microorganisms found by sonication analysis were
evaluated for antibiotic suitability.
Results
We included 28 implants from 20 patients, all females, into our study of which 6 implants
(21.4%) were excluded because of clinical infection (pain, redness, swelling of breast). Mean
age at explantation was 48 (range 19–75) years.
22 implants were included into further analysis, of which 16 (72.7%) were implanted for
aesthetic reasons, and 6 (27.3%) for reconstructive reasons. Mean implant indwelling time was
16.7 (1–34.4) years. Data on location of implants was available for 16 of 22 implants (72.7%),
of which 10 (45.5%) were positioned subglandular, 5 (22.7%) subpectoral and 1 (4.5%) was
positioned underneath a latissimus dorsi muscle flap. Implant surface details were available for
19 of 22 implants (86.4%), of which 13 (68.4%) were textured, 3 (15.8%) were smooth, and 2
(10.5%) had a polyurethane surface.
The main reason for explantation was capsular contracture, with 21 (95.5%) of 22 implants,
of which 7 implants were also ruptured. 1 (4.5%) implant was explanted due to patient request.
Of 22 analyzed implants 1 (4.5%) was explanted from a breast, showing no sign of capsular
contracture (Baker grade 1) and 21 (95.5%) implants came from breasts, which showed consid-
erable capsular contracture, with 17 (80.9%) implants from breasts classified Baker grade 3,
and 4 (19%) implants from breasts classified Baker 4.
Sonication results
Culture results after sonication showed that out of 22 analyzed implants, 3 (13.6%) were cul-
ture negative, and 19 (86.4%) were culture positive, of which 1 (5.3%) with Propionibacterium
avidum and 18 (81.8%) with Coagulase-negative staphylococci (CNS). 18 of 21 (85.7%)
implants, which were explanted from breasts with capsular contracture (Baker 3/4) had posi-
tive sonication results. Since only one implant was explanted from a breast without signs of
capsular contracture, a correlation analysis of positive culture results and rate of capsular con-
tracture was not reasonable.
Table 1. Microorganisms found by sonication of breast implants.
Reischies et al 2017 Pajkos et al. 2003 Del Pozo et al. 2009 Rieger et al. 2013
Number of implants 28 27 (100%) 45 121
Number of implants excluded due to infection 6 0 0 9
Number of implants included 22 27 45 112
Degree of capsule contraction
Baker 1–2 1/22 (4.5%) 8/27 (29.6%) 18/ 45 (40%) 22/89 (24%)
Baker 3–4 21/22 (95.5%) 19/27 (70.4%) 27/45 (60%) 68/89 (76%)
Sonication results capsules n = 27
Culture-positive 19/22 (86.4%) 18/27 (66.6%) 10/45 (22.3%) 40/89 (45%)
Culture-negative 3/22 (13.6%) 9/27 (33.3%) 35/45 (77.7%) 49/89 (55%)
Coagulase-negative staphylococci 18/19 (94.7%) 15/18 (83.3%) 5/10 (50%) 16 /40 (40%)
Propionibacterium spp 1/19 (5.3%) 2/18 (11.1%) 5/10 (50%) 18/40 (45%)
Bacillus spp. 0 1/18 (5.5%) 0 3/40 (7.5%)
Others 0 0 0 3/40 (7.5%)
Table 1, showing sonication results of breast implants and capsules from different publications: Pajkos 2003, Del Pozo 2009, Rieger 2013 and Reischies
2017. Coagulase-negative staphylococci and Propionibacteria were most often found.
https://doi.org/10.1371/journal.pone.0182267.t001
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Sonication results from previously published paper
Seven studies matched our initial search, after further screening five papers were found report-
ing of breast implant sonication results, of which all were published after 2000, and two
excluded from further analysis due to overlapping patient cohorts[15][16], (Table 1).
Pajkos et al analyzed 21 implants and 27 capsule-pieces from 16 patients. Capsule material
and, if available, implant material was analyzed after maceration by sonication. Of all sonica-
tion results in this study n = 48, 24(50%) were positive, of which 18/24 (75%) grew CNS, with
significant association of CNS positivity and the presence of Baker grade 3/4[9]. Del Pozo
analyzed 45 implants from 29 women. There was a significant difference between implants
explanted due to capsular contraction and implants explanted for other reasons, regarding
positivity of sonication culture results (p = 0.034). The main group of isolated bacteria found
were CNS and Propionibacterium spp[10]. Rieger analyzed 121 breast implants from 84
patients of which nine were excluded because of clinical infection. There was a significant cor-
relation between degree of capsular contracture and culture positivity after sonication. The
main group of bacteria found were Propionibacteria spp and CNS[11].
Antibiotic agents recommended by guidelines for perioperative
prophylaxis
Despite some conflicting reports on antibiotic prophylaxis for breast implantation surgery[17]
[18], all reviewed guidelines recommended the use of antibiotic prophylaxis for breast implant
surgery. The Sanford guide to antimicrobial therapy recommends cefazolin, 1-2mg iv single-
shot preoperatively for breast surgery[19]. ASHP therapeutic guidelines recommend antibiotic
prophylaxis for breast implantation surgery, as they count the implant as a risk factor for infec-
tion[20]. Also according to SIGN guidelines (updated 2014), in breast surgery involving
implants for reconstructive or aesthetic reasons antibiotic prophylaxis is recommended[21].
Systemic reviews also recommend the use of antibiotic prophylaxis in breast implantation sur-
gery[22][23]. In all reviewed guidelines cephalosporins are most often recommended.
These recommondations are congruent with the recent report of 97% of plastic surgerons
using cefazolin for this type of surgery [14].
However, there is a discrepancy between optimal antibiotic efficacy of cephalosporines and
microorganism found by sonication, which are high-profile suspects to trigger the formation
of capsular contracture (Table 2).
Discussion
The detection and identification of microorganism on breast implants by sonication, explanted
from breasts with capsular contracture, substantiated the hypothesis of an infectious etiology
of capsular contracture. The strong link between these microorganisms and capsular contrac-
ture was supported by Tamboto et al, who has demonstrated a causal link between subclinical
infection, biofilm formation, and capsular contracture in a porcine model[24].
Microorganism found by sonication form part of the skin flora, which are generally consid-
ered to have low virulence[25]. Fig 1 depicts possible sources of these microorganisms found
on breast implants. Possible contamination of the implant during surgery may occur during
contact with the skin flora (patient, surgeon, scrub personnel etc.)[26][27]. Contamination
may also occur from microorganisms originating from breast ducts or glands, or result from
asymptomatic bacteraemia of the patient[28][29].
Studies which reported methods to reach lower rates of capsular contracture describe meth-
ods to improve prevention of contamination of breast implants. Manual pocket dissection
Antibiotic prophylaxis for capsular contracture
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technique compared to diathermy dissection was reported to increase capsular contracture
rates sevenfold in a study with 3002 patients[30]. A no-touch technique was proposed to
reduce the risk of capsular contracture, since Mladick 1993 published a contracture rate of 0.6
percent in 2863 patients with a 17 year follow-up[5]. The implantation of suction drains were
reported to increase the risk of capsular contracture more than fourfold[30]. Implants placed
under the pectoral muscle have been reported to be associated with a decreased capsular con-
tracture rate[31]. In the case of a periareolar implantation, the incidence of capsular contrac-
ture was 9.5 compared to 0.59 in the case of an inframammary access[6]. All of which
presumably reduced the risk of contamination by the natural microbial flora of the breast
ducts, by avoiding opening of breast gland ducts and allowing for a larger distance between
breast gland and the implant. A systematic review showed no reproducible data regarding the
Table 2. Antibiotic activity against different microorganism.
















Benzylpenicillin - - - + - - -
Ampicillin/
Amoxicillin
- - - + v v -
Co-amoxiclav + - - + + + -
Flucloxacillin + - v - - - -
Cephalosporins
Cefradine + - v + + v -
Cefuroxime + - v + + + -
Ceftriaxone + - - + + + -
Ceftazidime - - - - + + +
Macrolides/Lincosamides
Erythromycin + v - + - - -
Clarithromycin + v - + - - -
Clindamycin + v v - - - -
Aminoglycosides
Gentamicin + + v - + + +
Diaminopyrimidines
Trimethoprim v v - - + + -
Quinolones
Ciprofloxacin + - - - + + +
Levofloxacin + - - + + + +
Glycopeptides
Vancomycin IV + + + + - - -
Teicoplanin + + + + - - -
Nitroimidazoles
Metronidazole - - - - - - -
Tetracyclines
Doxycycline + + v + - - -
Table 2, showing ineligibility of cephalosporins against staphylococcus epidermidis (coagulase negative staphylococci—CNS) and suitability of
glycopeptide antibiotics against staphylococcus epidermidis (coagulase negative staphylococci—CNS). From „Antibiotic prophylaxis in Surgery”Scottish
Intercollegiate Guideline Network, updated 2014.
„v”indicates variable antibiotic susceptibility according to local epidemiology.
https://doi.org/10.1371/journal.pone.0182267.t002
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association between type of implant surface and formation of capsular contracture[32]. The
successful identification of microorganisms on breast implants with capsular contracture in
recent years should be used to apply targeted antibiotic prophylaxis against the detected micro-
organisms for the prevention of capsular contracture.
Gylbert et al reported no significant difference in capsular contracture between two groups
of patients, one receiving penicillin antibiotic prophylaxis perioperatively for breast implant
surgery[12] These findings are in accordance with those of Mirzabeigi et al, who showed in a
Fig 1. Contamination of breastimplants. Fig 1, showing possible sources of implant contamination;
counterclockwise starting in the upper left corner (1) surgical access (marked in red: axillary, periareolar and
inframammary), (2) implant contact with breast parenchyma (marked in blue: subglandular and infrapectoral
implant placement), (3) contact with skin flora (patient, surgeron, scrup personnel), (4) haematogenous spread
from asymptomatic bacteraemia.
https://doi.org/10.1371/journal.pone.0182267.g001
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large cohort of primary and secondary breast augmentations, that three days of postoperative
administration of cephalosporins did not not result in lower rates of complications such as
infections or capsular contracture[33]. However, penicillin and cephalosporin antibiotics
(beta-lactam antibiotics) do not provide suitable activity against microorganisms found on
implants by sonication (Table 2)[34]. May et al reported 80% of CNS to be Oxacillin resistant
in over 500.000 CNS isolates in the United States from 1999–2012, Oxacillin was tested as the
antibiotic agent representative for beta-lactam antibiotics. Whereas, Vancomycin resistance in
CNS isolates was not detected[34]. These results are in conjunction with reports from Asia and
Europe where also very high rates of beta lactam antibiotic resistance (>70%–90%) in CNS
isolates were reported[35][36]. We were unable to retrieve any other studies investigating sys-
temic perioperative antibiotic prophylaxis for the prevention of capsular contracture.
Although many different microorganisms can cause infections, surgical site infections are
usually caused by a small number of common pathogens like staphylococcus aureus and beta-
haemolytic streptococci. Antibiotic prophylaxis in surgery focuses on elimination of pathogens
commonly responsible for surgical site infections (Fig 2). Microorganisms, which are sus-
pected to trigger capsular contracture are considered to be of low virolence, thus they are not
mainly targeted by currently recommended perioperative antibiotic regimens.
Therefore, cephalosporins, which are mostly used[14], do not provide sufficient activity
against organisms isolated from breast implants by sonication, suspected to trigger the forma-
tion of capsular contracture. Glycopeptide antibiotics are highly efficient against gram positive
organisms[34], like propionibacteria spp and CNS, the most frequently found microorganisms
by sonication on breast implants[11][10][9]. As a result, for an efficient prevention of capsular
contraction, glycopeptide antibiotics (Vancomycin) in addition to cephalosporins should be
considered for preoperative antibiotic prophylaxis in breast implant surgery.
The benefit of using the proposed single iv dose of Vancomycin additionally to the single
shot of cephalosporin, prior to breast implant surgery, results from the reliable antibiotic cov-
erage against these microorganisms found by sonication on breast implants and the microor-
ganisms typically responsible for surgical site infections. Vancomycin used alone as antibiotic
prophylaxis led to higher rates of surgical site infections due to methicillin-sensitive staphylo-
coccus aureus (MSSA)[37]. Actually Vancomycin plays a limited role in perioperative antibi-
otic prophylaxis, is only used in settings with high incidence rates of MRSA infections[38],
and for patients with allergies against beta-lactam antibiotics[19]. As a side effect, Vancomycin
has been reported to cause acute kidney injury and after fast infusion of Vancomycin a rash,
that can affect the whole body, known as the red-man syndrome [39][40]. Therefore, patients
considered for the proposed dual antibiotic regimen should be screened for kidney function
prior to its administration and Vancomycin should be injected slowly, over 60 min prior to
surgery.
Ideally biofilm formation and capsular contracture can be prevented by this targeted antibi-
otic prophylaxis of a cephalosporin in combination with Vancomycin, at a relatively low cost.
One dosage of iv Vancomycin amounts to under 3 Euro at our institution and kidney function
tests cost under 3 Euro. An acceptable trade-off, compared to the costs of possible revision sur-
gery in the case of high grade capsular contracture, with resultant capsulectomy and bilateral
implant exchange.
Breast implant operations have a considerably high share among aesthetic procedures,
which is small compared to the overall number of surgical procedures in general. Therefore,
the recommendation of a single iv dose of Vancomycin, interests only a negligible proportion
of all surgical procedures, has a well-defined indication, and is based on our as well as previ-
ously published data [41]. Vancomycin resistance especially in enterococci emerged after the
use of Avoparcin, a glycopeptid used as a growth promoter in food animals. Vancomycin
Antibiotic prophylaxis for capsular contracture
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resistant staphylococci in humans are still very rare despite Vancomycin being in place for
almost 60 years [34][41].
Other antibiotic substances which can also be taken into consideration due to activity
against CNS are Daptomycin and Trimethoprim/Sulfamethoxazole. Compared to Vancomy-
cin, Daptomycin does not cause the red man syndrome (flush after injection) and shows no
nephrotoxicity. However, one dose of Daptomycin costs about sixty times as much as one dose
of Vancomycin. In our region Trimethoprim/Sulfamethoxazole has only weak activity against
CNS with up to 30% resistance rates, and cannot be considered [35].
Local antibiotic solutions used during breast implant surgery such as local Gentamycin
solution, do not provide reliable antibiotic activity against CNS, and cannot prevent the forma-
tion of a CNS biofilm around the implant–in our region resistance rates of CNS against Genta-
mycin reach up to 40%. There is also no official licensing for Gentamycin for local wound
irrigation and the implants manufacturers do advice against the usage of any local wound solu-
tions like betadine due to the possible interaction with the implant surface with unknown
consequences.
Limitations include the retrospective design of our data review, and a possible non-exhaus-
tive retrieval of additional publications (no records were identified through other sources on
this topic as stated in the PRISM chart).
Conclusion
Antibiotic single-shot intraoperative prophylaxis for breast implant surgery should be focused
on eradication of CNS and propionibacteria, which seem to play a causative role in the forma-
tion of capsular contracture. Conventionally used cephalosporines alone for preoperative pro-
phylaxis predominantly applied for prevention of surgical site infections are not suitable to
eliminate organisms found to be associated with capsular contracture. We suggest to add Van-
comycin to this regimen prior to breast implant surgery to target microorganisms found to be
associated with capsular contracture, and aim to analyze the future outcome in a prospective
fashion.
Fig 2. Capsular contracture vs surgical site infections. Fig 2, Comparing capsular contracture and surgical site infections,
micoorganisms, virulence and antibiotic activity.
https://doi.org/10.1371/journal.pone.0182267.g002
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Winter, Martin J. Köfer, Lars P. Kamolz, David B. Lumenta.
Data curation: Frederike M. J. Reischies, Judith Holzer, Tobias Meikl, Martin J. Köfer.
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